{"id":"https://openalex.org/W7054636677","doi":null,"title":"Assessment of antibiotic resistance in pathogens causing \\nneonatal sepsis, associated mortality and recommended \\ntreatment options in low- and middle- income countries.","display_name":"Assessment of antibiotic resistance in pathogens causing \\nneonatal sepsis, associated mortality and recommended \\ntreatment options in low- and middle- income countries.","publication_year":2022,"publication_date":"2022-10-01","ids":{"openalex":"https://openalex.org/W7054636677"},"language":"en","primary_location":{"id":"pmh:oai:https://orca.cardiff.ac.uk:159120","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/159120/1/2023ThomsonK%20PhD.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/159120/1/2023ThomsonK%20PhD.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058552309","display_name":"Kathryn Thomson","orcid":"https://orcid.org/0000-0001-9314-3390","observed_orcids":["https://orcid.org/0000-0001-9314-3390"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Thomson, Kathryn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5058552309"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11961","display_name":"Neonatal and Maternal Infections","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11961","display_name":"Neonatal and Maternal Infections","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neonatal-sepsis","display_name":"neonatal sepsis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9150000214576721},{"id":"https://openalex.org/keywords/klebsiella","display_name":"Klebsiella","score":0.699999988079071},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.9779999852180481},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serratia-marcescens","display_name":"Serratia marcescens","score":0.9909999966621399},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.6970000267028809},{"id":"https://openalex.org/keywords/ampicillin-resistance","display_name":"ampicillin resistance","score":0.6320000290870667},{"id":"https://openalex.org/keywords/gentamicin-resistance","display_name":"gentamicin resistance","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cefotaxime-resistance","display_name":"cefotaxime resistance","score":0.7730000019073486},{"id":"https://openalex.org/keywords/ceftriaxone-resistance","display_name":"ceftriaxone resistance","score":0.9509999752044678},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.8500000238418579},{"id":"https://openalex.org/keywords/amikacin","display_name":"amikacin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.859000027179718},{"id":"https://openalex.org/keywords/antibiotic-prescribing-patterns","display_name":"antibiotic prescribing patterns","score":0.628000020980835},{"id":"https://openalex.org/keywords/neonatal-mortality","display_name":"neonatal mortality","score":0.8579999804496765},{"id":"https://openalex.org/keywords/low-and-middle-income-countries","display_name":"low- and middle-income countries","score":0.9549999833106995},{"id":"https://openalex.org/keywords/blood-culture","display_name":"blood culture","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.8446000218391418},{"id":"https://openalex.org/C2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","level":3,"score":0.758899986743927},{"id":"https://openalex.org/C2776021129","wikidata":"https://www.wikidata.org/wiki/Q244150","display_name":"Ampicillin","level":3,"score":0.7138000130653381},{"id":"https://openalex.org/C2778719061","wikidata":"https://www.wikidata.org/wiki/Q417968","display_name":"Cefotaxime","level":3,"score":0.6996999979019165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6559000015258789},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.5835000276565552},{"id":"https://openalex.org/C183641309","wikidata":"https://www.wikidata.org/wiki/Q306264","display_name":"Amp resistance","level":4,"score":0.555400013923645},{"id":"https://openalex.org/C2775953899","wikidata":"https://www.wikidata.org/wiki/Q6993495","display_name":"Neonatal sepsis","level":3,"score":0.5526000261306763},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5493000149726868},{"id":"https://openalex.org/C2775832221","wikidata":"https://www.wikidata.org/wiki/Q422482","display_name":"Gentamicin","level":3,"score":0.5228999853134155},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.48170000314712524},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.43140000104904175},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3912000060081482},{"id":"https://openalex.org/C2779116282","wikidata":"https://www.wikidata.org/wiki/Q131854","display_name":"Klebsiella","level":4,"score":0.3741999864578247},{"id":"https://openalex.org/C2779473907","wikidata":"https://www.wikidata.org/wiki/Q886695","display_name":"Blood culture","level":3,"score":0.3346000015735626},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.3276999890804291},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.3228999972343445},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3151000142097473},{"id":"https://openalex.org/C2776450100","wikidata":"https://www.wikidata.org/wiki/Q134980","display_name":"Serratia","level":4,"score":0.30979999899864197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28679999709129333},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2750999927520752},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.2651999890804291},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.258899986743927},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.25609999895095825}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:https://orca.cardiff.ac.uk:159120","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/159120/1/2023ThomsonK%20PhD.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/159120/1/2023ThomsonK%20PhD.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3151221590","https://openalex.org/W3190810782","https://openalex.org/W3134211318","https://openalex.org/W4386632066","https://openalex.org/W7213558461","https://openalex.org/W4385410425","https://openalex.org/W3211465988","https://openalex.org/W3203515993","https://openalex.org/W7206156417","https://openalex.org/W2415153367"],"abstract_inverted_index":{"Sepsis":[0],"is":[1],"a":[2,278],"leading":[3],"cause":[4],"of":[5,20,40,78,118,159,168,249,277],"neonatal":[6,28,243,305],"mortality,":[7],"particularly":[8],"in":[9,24,49,61,226],"low-":[10],"and":[11,54,76,89,120,140,154,189,203,209,218,221,224,230,233,256,283,293],"middleincome":[12],"countries":[13],"(LMICs).":[14],"Current":[15],"studies":[16],"evidence":[17],"alarming":[18],"rates":[19,158],"antimicrobial":[21],"\\nresistance":[22,119],"(AMR)":[23],"bacterial":[25,125],"pathogens":[26],"causing":[27],"sepsis,":[29],"however,":[30],"these":[31],"are":[32],"often":[33,199],"single":[34],"site":[35],"studies,":[36],"limiting":[37],"the":[38,79,105],"extrapolation":[39],"data":[41,72],"to":[42,104,172,206,228,246,288,295,309],"inform":[43],"policy":[44],"change.":[45],"\\nBARNARDS":[46],"was":[47,81,86,182,261],"undertaken":[48],"12":[50],"sites":[51,60,292],"across":[52,132],"Africa":[53],"South":[55],"Asia.":[56],"Mothers":[57],"attending":[58],"clinical":[59],"labour":[62],"or":[63],"presenting":[64],"neonates":[65,90],"with":[66,135,166,275],"suspected":[67],"sepsis":[68,244,306],"were":[69,102,127,148,161,212,286],"enrolled":[70],"\\nand":[71],"regarding":[73,271],"mother":[74],"socio-demographics":[75],"birth":[77],"neonate":[80],"collected.":[82],"Associated":[83],"antibiotic":[84,259],"use":[85],"collated":[87],"retrospectively,":[88],"followed":[91],"up":[92],"for":[93,107,195,242,270,304],"60":[94],"days.":[95],"Isolates":[96],"grown":[97],"from":[98,129,201],"positive":[99],"blood":[100,130],"cultures":[101,131],"sent":[103],"UK":[106],"further":[108],"analyses,":[109],"including":[110,216],"minimum":[111],"inhibition":[112],"concentrations,":[113],"whole":[114],"genome":[115],"sequencing,":[116],"frequency":[117],"pathogenicity":[121],"indexing.":[122],"Over":[123],"30":[124],"species":[126],"identified":[128,144],"BARNARDS":[133],"\\nsites":[134],"Klebsiella":[136,152],"spp.,":[137],"E.":[138],"coli":[139],"Staphylococcus":[141],"aureus":[142],"most":[143],"discounting":[145],"outbreaks,":[146],"which":[147,265],"prominently":[149],"caused":[150],"by":[151,214],"spp.":[153],"Serratia":[155],"marcescens.":[156],"High":[157],"AMR":[160],"seen":[162],"against":[163,184],"multiple":[164],"antibiotics,":[165],"71.5%":[167],"Gram-negative":[169],"bacteria":[170],"resistant":[171],"ampicillin":[173,202,229],"and/or":[174],"gentamicin,":[175],"recommended":[176,185],"first-line":[177],"treatment.":[178],"Furthermore,":[179],"83%":[180],"resistance":[181,208],"found":[183],"second-line":[186],"treatments":[187],"cefotaxime":[188],"80%":[190],"\\nagainst":[191],"ceftriaxone,":[192],"slightly":[193],"reduced":[194],"ceftazidime":[196,223,234],"(60%).":[197],"Sites":[198],"veered":[200],"gentamicin":[204],"due":[205,245],"known":[207],"varied":[210,290],"antibiotics":[211],"prescribed":[213],"\\nsites,":[215],"piperacillin-tazobactam":[217],"amikacin,":[219,222],"amoxicillin-clavulanate":[220],"amikacin":[225],"addition":[227],"gentamicin.":[231],"Amikacin":[232],"could":[235,266],"act":[236],"as":[237],"potential":[238],"empirical":[239],"therapy":[240,303],"alternatives":[241],"lower":[247],"prevalence":[248],"resistance,":[250],"reported":[251,273],"survival,":[252],"current":[253],"usage,":[254],"cost,":[255],"availability.":[257],"However,":[258],"usage":[260,276],"uneven":[262],"between":[263,291],"countries,":[264],"not":[267],"be":[268,296,310],"accounted":[269],"\\niii":[272],"survival":[274],"specific":[279],"antibiotic.":[280],"Availability,":[281],"price":[282],"whether":[284],"costs":[285],"deferred":[287],"patients":[289],"needs":[294,308],"considered":[297],"when":[298],"deliberating":[299],"alternative":[300],"treatments.":[301],"Empirical":[302],"urgently":[307],"re-evaluated":[311],"\\nin":[312],"LMICs.":[313]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}